Hollywood Stars Conquer Allergy-Inducing "Pollen Vortex" in Newly Released AirWare Labs Video

"Mad Men" Star Vincent Kartheiser and Adam Herschman of "Accepted" Demonstrate the Power of Allergy-Free Breathing With AIR(R) Nasal Filters

SCOTTSDALE, AZ--(Marketwired - May 29, 2014) - With this year's allergy season in full swing, AirWare Labs Corp. (OTCQB: AIRW) has released a video starring TV and movie personalities Vincent Kartheiser and Adam Herschman that demonstrates the effectiveness of AIR® nasal filters against airborne allergens. Kartheiser currently plays "Pete Campbell" on AMC's drama Mad Men, and Herschman is best known for his roles in hit comedies Accepted and Soul Men.

The video, titled Bubble Boy: AirWare Spokesperson Auditions, features Kartheiser's character in a humorous search for AirWare's new spokesperson. "Bubble Boy," played by Herschman, wins the job after telling the story of his life spent in a protective bubble -- until his discovery of AIR® filters allowed him to escape from the bubble and live, and breathe, freely.

"This project has been thrilling from start to finish," said Jeffrey Rassás, CEO of AirWare Labs. "Working with Vincent and Adam was incredible, and the video demonstrates their ability to capture and hold an audience with just the right mix of energy and humor. 'Bubble Boy' is the ultimate spokesperson for AirWare, and we are confident his story will reach millions of allergy sufferers struggling through this prolific allergy season."

Designed with an integrated filter media from 3M, AIR filtered inserts protect wearers from up to 99% of plant spores, airborne pollens and viruses. AIR filters provide an effective solution to this year's severe allergy season -- one the media attributes to a "Pollen Vortex," the result of a long, cold winter and subsequent blooming of pollen-producing trees all at one time. In fact, WebMD predicts this will be the worst allergy season in the last four years.

"With what we're hearing from our customers and in the news about the severity of allergies right now, our video release couldn't be more timely," said Rassás.

To help maximize online distribution, AirWare has partnered with a well-known social video and seeding company. "By combining our social media, marketing and PR campaign with our partner's network of publishers and social platforms, we are able to greatly amplify the reach of our video," said Chase Herschman, Director of Marketing for AirWare Labs. "Timing is everything, and our distribution plan is geared to reach the largest possible audience right when people are seeking a solution like AIR."

About AirWare Labs Corporation:

AirWare Labs Corp. [publicly traded as (OTCQB: AIRW)] provides patented and innovative technology solutions for consumer products that promote better health through breathing and enhanced wellbeing. AirWare Labs' products are marketed under the brand name of AIR®. AIR® products utilize an FDA approved medical grade material, molded as an intranasal Air Breathe dilator, to act as the delivery system. This AIR® microstructure enhances normal nasal airflow with every breath -- clinically proven to deliver up to 40% more oxygen.

Some AIR® products are infused with essential oils with unique healing properties including antibacterial and therapeutic defense against airborne allergens, viruses and bacteria. AIR® Allergy and Travel products provide additional defense in the form of an integrated filter media from 3M to remove microscopic particles that carry viruses, allergens and bacteria. Other AIR® specialty products help provide and performance enhancements and relief from congestion, insomnia, headaches, nausea, and snoring. For more product information, please visit: http://www.airwarelabs.com or company information visit: http://airwarelabscorp.com.

Forward-Looking Statement: The statements in this press release regarding any implied or perceived benefits from the release by AirWare Labs Corp. of its AIR® products are forward-looking statements. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, and the ability to manage and continue growth.

Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Media Contact: Jennifer Breitegan jen@kwprgroup.com Investor Relations: Keith Pinder Acorn Management 678-736-5682

Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Item 9 Labs (CE) Charts.
Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Item 9 Labs (CE) Charts.